DAWN Market Structure

Day One Biopharmaceuticals, Inc. (DAWN) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $2.22B, listed on NASDAQ, employing roughly 181 people, carrying a beta of -1.75 to the broader market. Day One Biopharmaceuticals, Inc. Led by Jeremy Bender, public since 2021-05-27.

Market structure data reveals where a stock trades across exchanges, dark pools, and alternative trading systems. Understanding off-exchange activity helps identify institutional trading patterns and liquidity dynamics.

Latest Week Ending

2026-04-20

Weekly OTC Shares

732.4K

Weekly OTC Trades

3.1K

12-Week Total Shares

64.0M

Avg Trade Size (12-Week)

325 shares

How Single-Name Off-Exchange Volume Affects Options

For single-name equities, persistent off-exchange volume concentrations can flag institutional positioning - large blocks arranged through ATS venues to avoid lit-market impact, or correlation-arbitrage flow from sector rotation. The flow doesn't directly move the lit-market price (it prints at the ATS) but it changes the inventory position of the institutional counterparty, which then drives subsequent lit-market flow. Compare the off-exchange volume series above with DAWN's gamma exposure and options volume history to see whether unusual dark-pool activity coincides with rebalancing in the options book.

Showing 12 weeks of off-exchange trading data for Day One Biopharmaceuticals, Inc..

Learn how market structure is reported and how to read the data →